Matignon Launches Major New European Device Fund
This article was originally published in Start Up
Executive SummaryEurope has a remarkable tradition of clinical thought leaders who develop major new medical device technologies. Yet European device company start-up activity lags far behind the rate of clinical breakthroughs. There are several reasons for this, including the dearth of European venture capital willing to back these start-ups. Matignon Technologies sees this gap in financing of European device start-ups as an opportunity, and has just launched one of the largest European funds dedicated primarily to medical technology.
You may also be interested in...
A surge in Chinese applications for clinical trials for coronavirus treatments, and a fall in patient numbers, are complicating recruitment efforts for the most promising drugs, prompting official moves to tighten study rules.